newsfilter
← Latest News
PR Newswire·

Oncopeptides publishes the 2021 Annual Report

STOCKHOLM, April 21, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (NASDAQ:ONCO) (Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, today announces that the 2021 Annual Repor